Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study
Open Access
- 1 November 1990
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 62 (5) , 781-785
- https://doi.org/10.1038/bjc.1990.379
Abstract
Using bivariate flow cytofluorometry, we have determined the nuclear DNA distribution and the expression of the p21 protein (coded by the Ha-ras oncogene) in the bone marrow (BM) cells of five solid tumour patients having histologically normal BM and in those of 57 patients with plasma cell dyscrasia (28 with monoclonal gammopathies of undertermined significance, MGUS, and 29 with multiple myeloma, MM). All normal and MGUS and 21/29 (72.4%) MM BM had diploid modal DNA content and 8/29 (27.6%) MM BM had both diploid and hyperdiploid cell populations. In normal and MGUS BM, the level of the p21 oncoprotein was low and uniform in all G0/G1, S and G2 cells (median fluorescence values in arbitrary units were 6.1 and 7.5, respectively). The level of p21 was increased both in different aliquots of G0/G1 cells and in the S and G2 cells in diploid MM (median value for G0/G1 cells was 20), and especially in MM with hyperdiploid clones (median value for hyperdiploid cells was 40.5, P less than 0.005 with respect to normal and MGUS BM and less than 0.005 with respect to diploid MM BM). The p21 expression was greater in patients with advanced (stage III) than in earlier MM (stages I + II) (P less than 0.005), and it was directly related to the BMPC infiltration (r = 0.7; P less than 0.005). Since p21 expression is greater in MM than in both normal and MGUS BM, Ha-ras could be involved in the malignant plasma cell transformation that distinguishes MM from MGUS.Keywords
This publication has 35 references indexed in Scilit:
- Monoclonal gammopathies: New approaches to clinical problems in diagnosis and prognosisBlood Reviews, 1989
- Ras oncogene mutation in multiple myeloma.The Journal of Experimental Medicine, 1989
- Mutations of the Kirsten-ras proto-oncogene in human preleukaemiaNature, 1987
- Oncogenes, cancer and analytical cytologyCytometry, 1986
- Ha-ras hypervariable alleles in myelodysplasiaNature, 1986
- ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.The Journal of Experimental Medicine, 1985
- Reversibility of the transformed and neoplastic phenotype. IV. Effects of long-term interferon treatment of C3H/10T1/2 cells transformed by methylcholanthrene and SV40 virusInternational Journal of Cancer, 1984
- Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogeneBiochemical and Biophysical Research Communications, 1984
- Cellular Transforming GenesScience, 1982
- Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.The Journal of cell biology, 1975